Anaphylaxis in Public Health
- 1 January 2019
- journal article
- review article
- Vol. 40, 3-10
Abstract
The increasing number of patients with anaphylactic reactions is a modern challenge for healthcare professionals in clinical practice and public health professionals. It remains difficult to determine the prevalence or incidence of anaphylaxis in the population due to the long absence of a consensus definition, the fact that analyses are performed on various population groups and the use of different data collection methodologies. In the United States, anaphylaxis mortality ranges from 0.63 to 0.76 cases per million inhabitants, with 58% of these deaths due to drug anaphylaxis. The risk factors for anaphylaxis are ramipril and metoprolol use, which is common in patients with cardiovascular disease. Also, a higher level of gliadin following excess gluten intake is associated with a higher incidence of anaphylaxis. Drugs, food and insect stings have long been known as anaphylaxis inductors. In diagnosis, determination of serum tryptase concentration is used. In patients with normal tryptase concentration, it is appropriate to screen other inflammatory mediators. The authors of this article present new findings on anaphylaxis in the literature and recommended practices of professional societies in the context of public health.Keywords
This publication has 50 references indexed in Scilit:
- Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rareJournal of Allergy and Clinical Immunology, 2014
- Angiotensin‐converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build‐up phaseClinical & Experimental Allergy, 2014
- Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SMJournal of Allergy and Clinical Immunology, 2014
- Retrospective Study of Drug-induced Anaphylaxis Treated in the Emergency Department or Hospital: Patient Characteristics, Management, and 1-Year Follow-upThe Journal of Allergy and Clinical Immunology: In Practice, 2013
- Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's adverse event reporting system and review of case reports in the literatureExpert Opinion on Drug Safety, 2013
- European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocutionResuscitation, 2010
- The etiology and incidence of anaphylaxis in Rochester, Minnesota: A report from the Rochester Epidemiology ProjectJournal of Allergy and Clinical Immunology, 2008
- Anaphylaxis following quadrivalent human papillomavirus vaccinationCMAJ : Canadian Medical Association Journal, 2008
- Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003Journal of Allergy and Clinical Immunology, 2004
- Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organizationJournal of Allergy and Clinical Immunology, 2004